Cleveland Clinic granted Apeiron an exclusive one-year option to license its SRC homology protein tyrosine phosphatase 1 inhibitors to treat cancer

Cleveland Clinic

U.S. / Non-Profit or Major Disease Foundation

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Apeiron Biologics AG

Austria / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced